dr. rer. nat. rebaz h. ali - · pdf filedr. rer. nat. rebaz h. ali . ... • pharmaceutical...
TRANSCRIPT
University of Sulaimani School of Pharmacy Dept. of Pharmaceutics 1st semester
Dr. rer. nat. Rebaz H. Ali
1/10/2017 Pharmaceutical Compounding 2
Outlines
• Introduction
• Clarification
• Water
• Aromatic water
• Syrups
1/10/2017 Pharmaceutical Compounding 3
Introduction
• Pharmaceutical necessities or adjuvants, are substance which added to improve the
“elegance” of the product.
• Pharmaceutical formulation is said to be “elegant” if it meets three standards of
quality. It should be
• Stable
• Palatable
• Therapeutically effective.
• Syrups and Aromatic waters are designed to provide a base which will produce
palatable medicinal products.
1/10/2017 Pharmaceutical Compounding 4
Shelf-life
• Stability is the extent to which a product retains within specified limits and throughout
its period of storage and use (i.e., its shelf life) the same properties and characteristics
that it possessed at the time of its manufacture.
• Five types of stability concern pharmacists:
1. Chemical: Each active ingredient retains its chemical integrity and labeled potency
within the specified limits.
2. Physical: The original physical properties, including appearance, uniformity, and
etc.
3. Microbiological
4. Therapeutic
5. Toxicological
1/10/2017 Pharmaceutical Compounding 5
Shelf-life
• Shelf life: may be defined as the time required for the drug level in a product stored at
room temperature (normally 25 oC) to degrade to 90 % of its labeled potency.
• Chemical changes which may be observed include hydrolytic degradation and auto-
oxidation (temperature, light, and humidity)
• Physical changes include precipitation and alteration in color, odor and viscosity.
1/10/2017 Pharmaceutical Compounding 6
Outlines
• Introduction
• Clarification
• Clarification methods
• Settling
• Filtration
• Water
• Aromatic water
• Syrups
1/10/2017 Pharmaceutical Compounding 7
Clarification
• Clarification is an operation which involves the removal of suspended matter from a
fluid medium.
• In pharmaceutical processing there are two main reasons for such processes:
• to remove unwanted solid particles from either a liquid product or from air
• to collect the solid as the product itself (e.g. following crystallization).
• The specific procedures and equipment which may be used to achieve clarification are
dependent on:
• The particle size of the suspended matter.
• The physical state of the suspended matter.
• The quantity of suspended matter.
• The characteristics of the fluid medium.
• The speed of the operation.
1/10/2017 Pharmaceutical Compounding 8
Settling
• The simplest method of clarification is to allow the liquid to stand in a suitable
container until the suspended matter either has settled or has risen to the top of the
liquid.
• The insoluble matter may be separated from the clear liquid phase by skimming,
decantation, or siphoning.
Skimming Decantation Siphoning
1/10/2017 Pharmaceutical Compounding 9
Settling cont.
• Settling process fails if
• The suspended matter is colloidal
• The density of the suspended particles is approximately equal to that of liquid
phase.
• Acceleration of the settling process can be accomplished by centrifugation.
1/10/2017 Pharmaceutical Compounding 10
Filtration or straining
• Filtration is the process of removing solid particles from a fluid by passing the
suspension through porous, fibrous, or granular substances.
• A filter or strainer is a surface upon which solids are deposited.
• It consists essentially of a medium which contains numerous pores which may
vary in size and shape and may be characterized by a high degree of tortuosity.
• They cats by impeding the passage of suspended particles with diameters greater
than that of the pores, while allowing the liquid to pass.
1/10/2017 Pharmaceutical Compounding 11
Filtration or straining cont.
• Ultra-filters are filters which are retentive to colloidal matter.
• The rate of filtration, is the volume of liquid passed, through the filter per unit time.
• Rate of filtration =(𝑓𝑖𝑙𝑒𝑟 𝑎𝑟𝑒𝑎)∗(𝑑𝑟𝑜𝑝 𝑝𝑟𝑒𝑠𝑠𝑢𝑟𝑒)
𝑙𝑖𝑞𝑢𝑖𝑑 𝑣𝑖𝑠𝑐𝑜𝑠𝑖𝑡𝑦 ∗(𝑓𝑖𝑙𝑡𝑒𝑟 𝑟𝑒𝑠𝑖𝑠𝑡𝑎𝑛𝑐𝑒)
1/10/2017 Pharmaceutical Compounding 12
Filtration or straining cont.
• Pressure drop is neglected if:
• Highly retentive filters are used.
• Highly viscous liquids such as syrup are being filtered
• Suction filtration increases the pressure drop by lowering the pressure beneath the
filter.
1/10/2017 Pharmaceutical Compounding 13
Filtration or straining cont.
• Properties of filter media
• Capable of delivering a clear filtrate at suitable production rate.
• It must withstand mechanical stresses without rupturing.
• No chemical or physical interactions with the components of the filtrate should
occur.
1/10/2017 Pharmaceutical Compounding 14
Filtration or straining cont.
• Types of filter media
• Sheet of woven material: like cotton, wool, synthetic material such as nylon and
filter paper.
• Unwoven fibrous materials: like cotton and asbestos fibers.
• Porous plate: natural porous materials, like stone, porcelain and other ceramics.
• Membrane filters: like Millipore filters.
• Granular or powdered materials: like sand, charcoal, etc.
1/10/2017 Pharmaceutical Compounding 15
Filter aids
• Filter aids: They a fine surface deposit that screens out all
solids, preventing them from contacting and plugging the
filter medium.
• Mechanism of action:
• They form a layer of second medium which protects the
basic medium (precoat).
• They improve the flow rate by decreasing cake
compressibility and increasing cake permeability (admix).
• E.g. silica, aluminosilicate, cellulose, talc and carbon.
• Properties of filter aids: they should be inert, irregular,
insoluble, incompressible
Filter aid
Filter medium
1/10/2017 Pharmaceutical Compounding 16
Outlines
• Introduction
• Clarification
• Water
• Purification methods
• Aromatic water
• Syrups
1/10/2017 Pharmaceutical Compounding 17
Water
1. Water, U.S.P.: it can be used:
• In the washing and the extraction of crude drugs.
• In the preparation of products for external use.
Water can be divided into two general types:
1. Bulk water, which are typically produced on site where they are used.
2. Packaged water, which are produced, packaged and sterilized to preserve microbial
quality throughout their packaged shelf life.
• A 100 mL portion of official water contains not more than 100 mg of residue after
evaporation.
• These dissolved solids consist of the chlorides, the sulfate and the bicarbonates of
sodium, potassium, calcium and magnesium.
1/10/2017 Pharmaceutical Compounding 18
Water cont.
2. Purified water U.S.P.: Is used in the preparation of all medication containing water
except ampoules, injections.
• A 100 mL portion of official water contains not more than 1 mg of residue after
evaporation.
A. Distillation
• Distillation is a process that involves the
evaporation of water and then the condensation
of the resulting steam.
• It allows the removal of almost all of the organic
and inorganic impurities and achieves very-high-
quality water.
• It is also considered the safe way to avoid
microbial and endotoxin contamination.
1/10/2017 Pharmaceutical Compounding 19
Water cont.
B. ion-exchange
• An Ion-exchange resin is the beads that are typically porous (providing a high surface
area) and are insoluble in water.
• It is based on the ability of the resins to selectively adsorb either cations or anions,
and to release other ions based on their relative activity; thus the process is called
Ion-exchange.
• They are cationic (sulfonic acid and carboxylic acid) and anionic (amino).
1/10/2017 Pharmaceutical Compounding 20
Water cont.
• Advantages
• Elimination of the use of heat.
• Simpler equipment.
• Lower costs.
• Ease of production and storage.
• Water softening is the replacing of Mg++ and Ca++ ions found in hard
water with Na+ ions.
1/10/2017 Pharmaceutical Compounding 21
Water cont.
3. Water for injection, U.S.P. this is a pyrogen-free water, purified by distillation, for the
preparation of products for parenteral use, it should prepared under aseptic condition.
• Pyrogens are fever-producing substances probably of bacterial origin; they probably
consist of polysaccharide-bearing antigens.
Heating at 250 oC for 30 minutes
Not more than 0.5o C
1/10/2017 Pharmaceutical Compounding 22
Water cont.
4. Sterile water for injection U.S.P., it is prepared from water for injection that is
sterilized and suitably packaged.
• It contains no antimicrobial agent or other added substance.
• It is not suitable for intravascular injection without its first having been made
approximately isotonic by the addition of a suitable solute.
• It is used for the reconstitution of other parenteral products, in most cases
antibiotics.
• Sterilization is the freeing of materials from all living organisms and
their spores.
• Methods of sterilization
1. Autoclave
2. Boiling the distilled water for at least 60 minutes in a tightly
closed flask
1/10/2017 Pharmaceutical Compounding 23
Water cont.
5. Bacteriostatic water for injection, U.S.P., it is prepared from water for injection that is
sterilized and suitably packaged.
• Containing one or more suitable antimicrobial agents.
• Typically is used for Multi-dose products that require repeated content withdrawal.
• It is contraindicated in newborns.
1/10/2017 Pharmaceutical Compounding 24
Outlines
• Introduction
• Clarification
• Water
• Aromatic water
• Methods for preparation of aromatic water
• Stability
• Syrups
1/10/2017 Pharmaceutical Compounding 25
Aromatic water
• These are aqueous solutions, usually saturated volatile substances characterized by very
low water-solubility.
• It’s providing a pleasantly flavored medium for the administration of water-soluble
drugs, and for liquid phase of emulsion and suspension.
• Examples
• Aromatic waters prepared from essential oils, like peppermint water, have been
used as carminative and antispasmodic.
• Rose water is a perfume
• Hamamelis water was used as a rub, astringent, perfume in aftershave lotions.
• Essential oil consists of hydrocarbon part called terpene (water-insoluble) and aromatic
carrier part (water-soluble)
1/10/2017 Pharmaceutical Compounding 26
Methods for preparation of aromatic water according to USP
1. Distillation: the odoriferous portion of the plant is added into a distillator with
sufficient purified water and then distilling most of the water.
• The excess oil is separated form the distillate.
• E.g. Rose Water, Orange Flower Water and Hamamelis Water
2. Solution
• The volatile substance is agitated with purified water for a period of time. The
mixture is then set aside for at least 12 hours, to ensure saturation, before it is
filtered through wetted filter paper.
• This method is simpler, quicker and more economical.
• E.g. chloroform water which is used as expectorant.
• When it is dispensed, the bottle should not be shaken, and only the
supernatant liquid should be used
• What will happen if you drink chloroform?
1/10/2017 Pharmaceutical Compounding 27
Methods for preparation of aromatic water according to USP cont.
3. Alternate solution
• Volatile substance + talc powder + purified water → mix for 10 min → filtration.
• Talc acts as distributing agent that accelerates the rate of solution by facilitating the
breaking up of the aromatic substance into fine particles.
• Some time surface active agent like polysorbate 80 (tween 80) can be used for
preparation of aromatic water.
• Disadvantage
• they foam excessively on agitation
• develop a disagreeable taste
• more easily subject to mold growth.
1/10/2017 Pharmaceutical Compounding 28
Stability
• Many waters support the growth of molds.
• The solutes are volatile materials, loss of aroma occurs on prolonged exposure to
elevated temperature. While lowering the temperature causes separation of the
aromatic component, thus producing cloudiness.
• The insoluble material may collect on the top of the liquid imparting the burning taste of
the first dose.
• Many of aroma-bearing solutes are oxidizable compounds and auto-oxidation can be
catalyzed by light.
• Chloroform water should be stored in light resistant bottle since light catalyze the
oxidation of chloroform to the poisonous gas (phosgene).
1/10/2017 Pharmaceutical Compounding 29